Close this search box.

On 13 July 2022, the Alliance for Patient Access’ Rare Diseases Working Group hosted a virtual discussion on primary hyperoxaluria type 1. Patients and stakeholders representing physicians and patients across the PH1 spectrum discussed patients’ experiences and identified ways to better support patients with this ultra-rare disease.

Read White Paper